497-72-3 (氧代环十二烷-9-烯-2,8-二酮,12-乙基-11-羟基-3,5,7,11-四甲基-4-[[3,4,6-三脱氧-3-(二甲胺基)-b-D-木糖基-吡喃己基]氧],(3R,4S,5S,7R,9E,11S,12R)-,Oxacyclododec-9-ene-2,8-dione,12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-4-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3R,4S,5S,7R,9E,11S,12R)-)

CAS号:
497-72-3
中文名称:
氧代环十二烷-9-烯-2,8-二酮,12-乙基-11-羟基-3,5,7,11-四甲基-4-[[3,4,6-三脱氧-3-(二甲胺基)-b-D-木糖基-吡喃己基]氧],(3R,4S,5S,7R,9E,11S,12R)-
英文名称:
Oxacyclododec-9-ene-2,8-dione,12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-4-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3R,4S,5S,7R,9E,11S,12R)-
分子式:
C25H43NO7
分子量:
469.611428499222

氧代环十二烷-9-烯-2,8-二酮,12-乙基-11-羟基-3,5,7,11-四甲基-4-[[3,4,6-三脱氧-3-(二甲胺基)-b-D-木糖基-吡喃己基]氧],(3R,4S,5S,7R,9E,11S,12R)-(497-72-3)名称与标识符

名称

英文别名:
Oxacyclododec-9-ene-2,8-dione,12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-4-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3R,4S,5S,7R,9E,11S,12R)-;(2R,3S,7R,9S,10S,11R)-10-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-me thyl-oxan-2-yl]oxy-2-ethyl-3-hydroxy-3,7,9,11-tetramethyl-1-oxacyclodo dec-4-ene-6,12-dione;(3R,4S,5S,7R,9E,11S,12R)-4-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-1-oxacyclododec-9-ene-2,8-dione;(3R,4S,5S,7R,9E,11S,12R)-12-Ethyl-11-hydroxy-3,5,7,11-tetramethyl-2,8-dioxooxacyclododec-9-en-4-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside;METHYMYCIN [MI];(3R,4S,5S,7R,9E,11S,12R)-12-ETHYL-11-HYDROXY-3,5,7,11-TETRAMETHYL-4-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)OXACYCLODODEC-9-ENE-2,8-DIONE;SCHEMBL654455;CHEBI:29630;LMPK04000037;Q27110190;OXACYCLODODEC-9-ENE-2,8-DIONE, 12-ETHYL-11-HYDROXY-3,5,7,11-TETRAMETHYL-4-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-, (3R,4S,5S,7R,9E,11S,12R)-;METHYMYCIN, (+)-;CHEMBL489347;UNII-16QGD97DXG;Methymycin;16QGD97DXG;DTXSID801023607;497-72-3;MT9;

标识符

InChIKey:
HUKYPYXOBINMND-HYUJHOPRSA-N
Inchi:
1S/C25H43NO7/c1-9-20-25(6,30)11-10-19(27)14(2)12-15(3)22(17(5)23(29)32-20)33-24-21(28)18(26(7)8)13-16(4)31-24/h10-11,14-18,20-22,24,28,30H,9,12-13H2,1-8H3/b11-10+/t14-,15+,16-,17-,18+,20-,21-,22+,24+,25+/m1/s1
SMILES:
O([C@H]1[C@@H]([C@H](C[C@@H](C)O1)N(C)C)O)[C@@H]1[C@H](C(=O)O[C@H](CC)[C@](C)(C=CC([C@H](C)C[C@@H]1C)=O)O)C |t:23|

氧代环十二烷-9-烯-2,8-二酮,12-乙基-11-羟基-3,5,7,11-四甲基-4-[[3,4,6-三脱氧-3-(二甲胺基)-b-D-木糖基-吡喃己基]氧],(3R,4S,5S,7R,9E,11S,12R)-(497-72-3)物化性质

实验特性

  • 熔点 : 195.5-197°
  • 酸度系数(pKa) : pKb 5.7(at 25℃)
  • 比旋光度 : D22 +61° (c = 0.7 in methanol), +74° (c = 1.1 in chloroform)

计算特性

  • 精确分子量 : 469.30395271g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 8
  • 可旋转化学键数量 : 4
  • 同位素质量 : 469.30395271g/mol
  • 重原子数量 : 33
  • 复杂度 : 711
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 10
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 1
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.7
  • 拓扑分子极性表面积 : 106Ų

氧代环十二烷-9-烯-2,8-二酮,12-乙基-11-羟基-3,5,7,11-四甲基-4-[[3,4,6-三脱氧-3-(二甲胺基)-b-D-木糖基-吡喃己基]氧],(3R,4S,5S,7R,9E,11S,12R)-(497-72-3)相关文献